Biotech Startups

SpotitEarly develops an at-home, non-invasive cancer pre-screening test that analyzes volatile organic compounds in exhaled breath samples using trained canines combined with its LUCID AI platform of biosensors and data analysis. The multi-cancer early-detection product is offered to consumers via online subscription and has been validated in clinical trials with healthcare institutions in Israel and the U.S.

1 investor

Spotlab develops customized AI models that turn clinical data into biomedical insights, identifying and quantifying digital biomarkers of disease progression and treatment response. Its applications span from blood cancers to neglected tropical diseases, such as detecting helminth eggs in stool samples, serving diagnostics and biopharma research.

1 investor

Sppare.me offers cryopreservation and storage of biological samples, keeping them in liquid-nitrogen tanks at an FDA-registered, state-licensed, CLIA-inspected lab. It operates through a partnership with the Diamond Institute for Infertility and Menopause, a US fertility center.

1 investor

Sprint Bioscience is a pharmaceutical company developing oncology drug candidates aimed at new treatments for hard-to-treat cancers. It uses a fragment-based drug discovery approach and out-licenses its drug programs to global pharmaceutical companies during the preclinical phase.

1 investor

Sprout Pharmaceuticals is a pharmaceutical company focused on women's sexual health, known for developing Addyi (flibanserin), the first FDA-approved treatment for low libido in women. It serves patients and healthcare professionals with evidence-based treatments for female sexual dysfunction.

1 investor

SprouTx is a Japanese company that develops plant-based meat and egg alternatives from sprouted soybeans and peas, designed for food manufacturers and ingredient buyers. The company uses proprietary sprouting technology to create meat-like textures and nutritional profiles suitable for various food applications.

1 investor

Spruce Capital Partners creates, advises, and invests in life sciences companies that make positive environmental impacts and improve human health and wellness.

1 investor

A biotech company dedicated to developing new vaccines, combining scientific expertise with commercial and operational capabilities.

1 investor

ST Pharm is a contract development and manufacturing organization (CDMO) producing active pharmaceutical ingredients, with a focus on gene therapy and nucleic acid technologies spanning oligonucleotides to xRNA.

1 investor

1 investor

Stablix is a preclinical-stage biotechnology company developing small-molecule medicines based on targeted deubiquitination therapeutics (TDT), using heterobifunctional molecules that recruit deubiquitinases (DUBs) to target proteins to restore protein stability and normal function. It focuses on treatments for cancer, rare diseases, and immunological disorders.

1 investor

STADA Arzneimittel AG is a pharmaceutical company based in Germany. No further business details provided on this investor relations contact page.

1 investor

Stago develops and manufactures hemostasis testing systems, analyzers, and reagents for clinical and laboratory diagnostics. Its products support blood coagulation and platelet function testing for laboratories, customers, and distributors.

1 investor

Standard Model Biomedicine develops foundation models for medical imaging, language, genomics, and pathology, leveraging expertise from leading pharmaceutical companies and research institutions.

1 investor

1 investor

Standing Ovation is a French protein company that uses precision fermentation to produce non-animal proteins such as casein (its patented Advanced Casein) and Tertia Protein, a single-cell protein for animal nutrition. Its products serve food and industrial manufacturers seeking dairy alternatives and lower-impact ingredients for applications ranging from cheese, yogurt and ice cream to vegan products.

1 investor

1 investor

STARLIMS offers a laboratory informatics platform combining LIMS, ELN, SDMS, LES, and advanced analytics software for R&D, quality control, and manufacturing teams to accelerate product development and automate lab workflows. The platform serves pharmaceutical, biotech, and manufacturing organizations managing complex lab operations and compliance requirements.

1 investor

Starna Therapeutics develops RNA-based therapeutic drugs focused on hepatic and extrahepatic targeted delivery technology. The company has built a proprietary platform of cationic lipids and lipid nanoparticles (LNPs) to achieve organ-specific delivery and is advancing clinical-stage mRNA vaccine and mRNA therapeutic candidates.

1 investor

The START Center for Cancer Research is a community-based early phase oncology research organization that runs clinical trials across a network of specialized units, having contributed to over 50 FDA/EMA-approved cancer therapies. It operates 15 research locations across the United States and Europe, working with community oncology centers, biopharma sponsors, and CROs.

1 investor

Startuplab.01 is a deep tech hub in Chile offering specialized laboratories (nearly 1,000m²) and collaborative workspaces for early-stage scientific and technological startups from TRL 4-5. It provides support and acceleration programs to help startups in fields such as biotechnology, agrifood, energy, and mining validate, pilot, and scale their technologies alongside industry.

1 investor

Stayble Therapeutics is a clinical-stage pharmaceutical company developing an injection-based treatment for disc herniation. The company is currently conducting phase 1b clinical trials for its therapeutic candidate.

1 investor

Steel Therapeutics is a pharmaceutical company that develops a pipeline of drug candidates and manages the associated regulatory, clinical, and product delivery work. It draws on pharmacy compounding and clinical trial expertise to bring medications to market.

1 investor

StemBioSys develops cell culture technology, including the patented CELLvo Matrix that replicates the body's physiological microenvironment to expand mesenchymal stem cells and specialty cells while preserving their stem-like properties. It supplies cells and cell expansion tools for stem cell research and regenerative medicine applications.

1 investor